“Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data” (2024) Swiss Medical Weekly, 154(10), p. 3704. doi:10.57187/s.3704.